About Nanoscribe
The medium-sized company develops and produces 3D printers and grayscale lithography systems as well as specially developed printing materials and application-specific solutions for various microfabrication applications. The specialist for additive manufacturing of high-precision structures and objects on the nano-, micro- and mesoscale was founded in 2007 as a spin-off of the Karlsruhe Institute of Technology (KIT) and is part of the BICO Group since June 2021. More than 4,000 users and operators at top universities and innovative companies worldwide benefit from the groundbreaking technology and application tailored solutions for 3D Microfabrication. Nanoscribe has created its strong market leading position through high quality engineering and agility to continuously develop its products to meet customers’ high expectations.
About Advanced BioMatrix
Advanced BioMatrix was founded in 2008 and is a leader in the life science of three dimensional (3D) applications for tissue culture, cell assay, bioprinting and cell proliferation. The products are recognized as the standard for purity, functionality and consistency. Advanced BioMatrix expertise and knowledge are being employed to assure that the products are of the highest quality, consistent from lot-to-lot and easy-to-use for researchers. Advanced BioMatrix materials have been cited in over 5000 publications by researchers worldwide. https://advancedbiomatrix.com/
About BICO
Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people’s health and lives for the better.
The company has a focus on developing technologies that will advance Health 4.0 Next Generation Core Industry Ecosystems that enable tissue engineering, diagnostics, multiomics, and cell line development. BICO’s technologies enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. We create the future of health.
The Group’s instruments in the field amounts to 25,000, including all the top 20 pharmaceutical companies, are being used in more than 65 countries, and have been cited in more than 9,500 publications. BICO is listed on Nasdaq Stockholm under BICO. www.bico.com
Captions
Image 1: Advanced BioMatrix hydrogels are suitable for Two-Photon Polymerization (2PP) based high-resolution 3D printing from left to right: PhotoChitosan®, PhotoDextran®, PhotoHA-Stiff® and PhotoGel®. The bioresins must be ordered in a kit with the appropriate photoinitiator for the 2PP-based printing process. For Two-Photon Polymerization, this is LAP.
Image 2: 3D printing hyaluronic acid (HA) from Advanced BioMatrix with Nanoscribe Quantum X bio: The 2.5D topographies printed with HA demonstrate the design freedom and flexibility, ranging from uniform to randomly structured membranes. Top: Printed structures from PhotoHA®-Stiff. Bottom: Designs for the printing job, progressing from an ordered (left) to a disorganized design (right).
Image 3: Animated GIF: Structures made of Advanced BioMatrix bioresin: 3D structure containing living NIH 3T3 fibroblast cells printed from a cell-loaded PhotoGel® (GelMA) bioresin. Cell viability one hour after printing is > 90% as determined by live-dead staining. The animation consists of several focus layers above and mainly within the printed structure.
Right of use and media relations
Our image may be used free of charge for editorial purposes. Please state the source as follows: "Image: Nanoscribe, www.nanoscribe.com". The image must not be used for commercial purposes or passed on to third parties.
In case of questions or if you would like to be added to our press mailing list, please do not hesitate to contact Dr. Saskia Braun, media@nanoscribe.com.
Stay up to date with our latest press releases about Nanoscribe and the world of 3D Microfabrication. Directly get in touch with us to discuss further press activities: Media relations
